Novel approach to primary T-cell editing through CRISPR-mediated gene engineering offers a scalable, precise solution for laboratories conducting primary immune research REDWOOD CITY, Calif. –EditCo Bio, Inc., a pioneer at the forefront of genome engineering innovation, today announced the launch of its Knockout CD4+ T-cell Pools. This latest addition to EditCo Bio’s product lineup marks […]
cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development; Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine SAN DIEGO — TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA manufacturing facility. […]
SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its groundbreaking Gibson SOLA platform. Going forward, the company will increasingly concentrate its efforts on expanding the adoption of Gibson SOLA for both DNA and […]
BICO Group AB today announces the appointment of Anders Fogelberg as Chief Commercial Officer (CCO). Commercial excellence has been defined as one of the top strategic priorities for BICO and this position is pivotal in setting and driving the strategy towards that target, i.e., in scaling the BICO business, increasing the commercialization efforts of the […]
Bruker Wins Competitive Auction Acquisition Ensures Continued Customer Access to NanoString’s Products Transaction Expected to Close in early-May 2024 SEATTLE–NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that substantially all of its assets will be acquired by Bruker Corporation (“Bruker”), a global […]
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 – $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif. – PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, 2024. Preliminary First Quarter Results Preliminary revenue of $38.8 million, roughly flat compared with $38.9 million in the prior-year period. Instrument revenue of $19.0 million compared with $20.7 million in the prior-year […]
CAMBRIDGE, Mass. — Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, announced today the issuance by the US Patent Office of a patent that covers the in situ imaging of the spatial transcriptome. U.S. Patent No. 11,959,075 is for robust multiplex imaging of RNA and its spatial organization […]
PLEASANTON, Calif. — Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, added a third instrument to its Sunny Suite for lipid nanoparticles (LNPs) today – Sunbather for GMP production of LNPs. Sunbather partners up with its upstream suite members, Sunscreen (formulation screening) and Sunshine (formulation optimization), making it a […]
IRVINE, CA – Zymo Research Corp., a leader in biotechnology innovation, has unveiled the company’s ‘Graduate Student Starter Pack’. This new program is dedicated to bolstering the next generation of life science researchers by providing them with complimentary, full-sized kits and essential laboratory supplies. The ‘Graduate Student Starter Pack’ caters to diverse research needs with four […]
Lexogen, a biotech company dedicated to advancing RNA research with innovative RNA-Seq products, is pleased to introduce solutions specifically optimized for transcriptomics from challenging FFPE samples. Transcriptome profiling of formalin-fixed paraffin-embedded (FFPE) samples, often referred to as “biobank” samples, provides invaluable information to researchers, especially those studying cancer, drug design and development. However, FFPE samples represent […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
-
2023 Dividend Changes for Laboratory Tool Companies Reflect a Chink in the Armor
January 31, 2024 5:45 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
